Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Molecules ; 25(12)2020 Jun 21.
Artículo en Inglés | MEDLINE | ID: mdl-32575811

RESUMEN

Metabolic syndrome includes a cluster of risk factors for many pathological conditions, including hyperglycemia, abdominal obesity, hyperlipidemia, and hypertension. Adansonia digitata L. (also known as baobab) is used in traditional African Medicine and recent studies showed that it improves the metabolism of carbohydrates and lipids. The aim of this study is to investigate the mechanisms of action associated with the beneficial effects of extracts from the edible parts of baobab (fruit pulp, leaves, raw and toasted seeds), evaluating their inhibitory activity against: alpha-amylase, alpha-glucosidase, angiotensin-converting enzyme, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, and pancreatic lipase. Baobab fruit pulp and leaf extracts resulted to be the most active ones and were then tested on the differentiation process of SW-872 human liposarcoma cells to mature adipocytes. The addition of these latter extracts did not affect triglyceride accumulation, indicating a neutral impact on this parameter. The findings here reported help to explain the growing amount of evidence on the biological properties of baobab and provide suggestions about their use in food and nutraceutical fields.


Asunto(s)
Adansonia/química , Diferenciación Celular/efectos de los fármacos , Síndrome Metabólico/tratamiento farmacológico , Extractos Vegetales/química , Extractos Vegetales/farmacología , Adipocitos/efectos de los fármacos , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Frutas/química , Inhibidores de Glicósido Hidrolasas/farmacología , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Quempferoles/química , Quempferoles/farmacología , Lipasa/antagonistas & inhibidores , Síndrome Metabólico/enzimología , Simulación del Acoplamiento Molecular , Hojas de la Planta/química , Quercetina/análogos & derivados , Quercetina/química , Quercetina/farmacología , Rutina/química , Rutina/farmacología , Semillas/química , alfa-Amilasas/antagonistas & inhibidores
2.
Food Chem Toxicol ; 129: 434-443, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31022478

RESUMEN

Mood disorders occur in 30% of stroke patients, and of these post-stroke depression (PSD) is the most significant. This study aimed to evaluate the antidepressive-like effects and in vivo antioxidant activity of a chemically characterized maqui berry (Aristotelia chilensis (Molina) Stuntz) extract obtained from an optimized extraction method, on a murine PSD model. The extraction process was optimized to maximize anthocyanin content, and the phytochemical profile of the extract was evaluated using a multi-methodological approach including a liquid chromatographic method coupled with mass spectrometry and nuclear magnetic resonance spectroscopy. The antidepressive-like activity was investigated through despair swimming and tail suspension tests. The in vivo antioxidant activity was evaluated in mouse brain tissue by measuring the activity of antioxidant enzymes and lipid peroxidation products. A number of compounds have been first identified in maqui berry here, including malvidin-glucoside, GABA, choline and trigonelline. Moreover, the results showed that the antidepressive-like activity exerted by the extract, which was found to restore normal mouse behavior in both despair swimming and tail suspension tests, could be linked to its antioxidant activity, leading to the conclusion that maqui berries might be useful for supporting pharmacological therapy of PSD by modulating oxidative stress.


Asunto(s)
Antidepresivos/farmacología , Depresión/tratamiento farmacológico , Elaeocarpaceae/química , Extractos Vegetales/farmacología , Accidente Cerebrovascular/tratamiento farmacológico , Animales , Antidepresivos/uso terapéutico , Depresión/etiología , Modelos Animales de Enfermedad , Ratones , Extractos Vegetales/uso terapéutico , Accidente Cerebrovascular/complicaciones
3.
Materials (Basel) ; 10(8)2017 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-28809799

RESUMEN

p-Cymene [1-methyl-4-(1-methylethyl)-benzene] is a monoterpene found in over 100 plant species used for medicine and food purposes. It shows a range of biological activity including antioxidant, anti-inflammatory, antinociceptive, anxiolytic, anticancer and antimicrobial effects. This last property has been widely investigated due to the urgent need for new substances with antimicrobial properties, to be used to treat communicable diseases whose diffusion in developed countries has been facilitated by globalization and the evolution of antimicrobial resistance. This review summarizes available scientific data, as reported by the most recent studies describing the antimicrobial activity of p-cymene either alone, or as the main component of plant extracts, as well as addressing the mechanisms of action of cymenes as antimicrobial agents. While p-cymene is one of the major constituents of extracts and essential oils used in traditional medicines as antimicrobial agents, but considering the limited data on its in vivo efficacy and safety, further studies are required to reach a definitive recommendation on the use and beneficial effects of p-cymene in human healthcare and in biomedical applications as a promising candidate to functionalize biomaterials and nanomaterials.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA